Neuroprotection Market at a CAGR of 8.2% during the forecast period between 2017 and 2030

Neuroprotection Market: Snapshot

The market for Neuroprotection is expected to grow at steady growth rate during the forecast period largely attributed due to increasing drug development in the pharmaceutical and biotechnology industry along with increasing patient population pool, growing incidences of CNS diseases, increasing awareness, increased demand for more target specific drug treatment for Neurodegenerative diseases along with favorable government regulations. The other factors responsible for the growth the market include increasing healthcare infrastructure, increasing economic stability in developing economies, increasing participation of major market players in in developing economies such as Latin America and Middle East & Africa. The North America region in Neuroprotection market is anticipated to hold major market share along with Europe region during the forecast period. The region are expected to grow moderately in comparison to Asia Pacific region during the forecast period whereas, primarily due to the effect of pricing pressure due to increased competition among leading brands, increase of generic products and growing number of regional players who are able to provide products at much lower prices. However, new product launch and robust pipeline are expected to enter Neuroprotection market, which are likely to increase future growth and demand of the Neuroprotection.

Get the sample copy of report@ https://qyresearchmedical.com/sample/112020

The global Neuroprotection market will increase at a CAGR of 8.2% during the forecast period between 2017 and 2025. Driven by the growing healthcare industry, increasing use of Neuroprotection in cosmetics, government initiatives, and rising ageing population, the market valued at US$ 23,170.6 Mn in 2016 in terms of revenue.

Based on product type the Neuroprotection market during 2016, the free radical trapping agents held a prominent share of approximately 36.4% of the global Neuroprotection market share. The segment is expected to expand at an equitable growth during the forecast period as equated to the other product types. The high growth segment in Neuroprotection drug class was the free radical trapping agents (Antioxidants) exhibiting a CAGR of 9.0% during the forecast period. The high growth is due to the increasing use antioxidants for treatment of neurodegenerative diseases such as Alzheimer’s and free radical trapping agents are more efficient in preventing further degradation of neural cells. Increasing demand for more efficient drug, increasing use of herbal extract free radical trapping agents such as cannabidiol, Vitamins E and C, and increasing research and development is expected to drive the market during the forecast period. Companies such as Biogen, Inc. have a robust product portfolio for treatment of neurological disorders such as, in June,2017, The European Commission (EC) has allowed an authorization of marketing to Biogen’s drug SPINRAZA (nusinersen), for treating 5q spinal muscular atrophy (SMA) in the European Union (EU).

Based on Application the Neuroprotection market has been segment into: prevention, and treatment. The treatment application is expected to expand at a higher CAGR during the period 2017-2025, whereas the prevention is expected to grow at a lower rate during the forecast period. Increasing demand for highly efficient drug delivery module is expected to drive the market growth.

View full report@ https://qyresearchmedical.com/report/neuroprotection-market-product-free-radical-trapping-agents-antioxidants-glutamate-antagonists-anti-excitotoxic-agents-apoptosis-inhibitors-anti-inflammatory-agents-neurotrophic-factors-ntfs-metal-ion-017-2030/112020

According to geography the global Neuroprotection market has been distributed into North America, Europe, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for highest share in the global Neuroprotection market in 2016, closely followed by Europe. Asia Pacific is anticipated to be the fastest growing market nonetheless Latin America region is projected to grow under the influence of North America, Europe, and Asia Pacific region due to lack of awareness in the region, but increasing government initiative to promote pharmaceutical and healthcare industry and increase in healthcare expenditure, are expected to boost the demand for Neuroprotection in this region. The changing demographics and rising per capita income of the middle class in pharmerging economies of the Asia and Latin America region such as India and other countries in rest of APAC region are expected to provide lucrative opportunities for the Neuroprotection market during the forecast period. The Middle East & Africa Neuroprotection market is expected to grow under the influence of increasing geographical presence of major manufacturers in the region through strategic mergers & acquisitions, increase in government initiatives to promote research and development pharmaceutical sector in the region is expected to drive the Neuroprotection market in the region during the forecast period.

Major players in the Neuroprotection market include Daiichi Sankyo Company, Eli Lilly and Company, Allergan plc, Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca plc, Astrocyte Pharmaceuticals, Inc., F. Hoffmann-La Roche AG, Biogen Inc., and other prominent players. Increasing product launches, geographical expansion in the developing economies, and increase in strategic alliances among regional and global manufactures is anticipated to further boost the neuroprotection market. For Instance, in November 2017, Teva Pharmaceutical received FDA approval for neurological and neuropsychiatry drug – Austedo, for treating Huntington disease and Tardive dyskinesia in the U.S.

Rising Cases of Chronic Illnesses such as Parkinson’s disease to Propel Neuroprotection Market

The market for Neuroprotection is required to develop at consistent development rate during the conjecture time frame generally ascribed because of expanding drug improvement in the drug and biotechnology industry alongside expanding patient populace pool, developing occurrences of CNS illnesses, expanding mindfulness, and expanded interest for more objective explicit medication treatment for Neurodegenerative sicknesses alongside good unofficial laws. Different components answerable for the development the market incorporate expanding medical services framework, expanding financial steadiness in creating economies, expanding cooperation of significant market major parts in creating economies like Latin America and Middle East and Africa.

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/112020/2900

Expanding interest for more proficient medication, expanding utilization of home grown concentrate free extreme catching specialists, for example, cannabidiol, Vitamins E and C, and expanding innovative work is required to drive the market during the conjecture time frame. Organizations like Biogen, Inc. have a hearty item portfolio for treatment of neurological problems, for example, in June,2017, The European Commission (EC) has permitted an approval of showcasing to Biogen’s medication SPINRAZA (nusinersen), for treating 5q spinal strong decay (SMA) in the European Union (EU).

Fast expansion in drug area and expanding patient populace has prompted an expanded interest for neuroprotective medications as they end up being profoundly effective in treatment of neurodegenerative illnesses like Alzheimer’s, Parkinson’s, Macular Sclerosis, and different infections where neural harm happens. These drivers alongside expanding rates of horrendous cerebrum injury are required to drive the Neuroprotection market in the foreseeable future.

The changing socioeconomics and rising per capita pay of the working class in pharmerging economies of the Asia and Latin America area, for example, India and different nations in rest of APAC district are required to give worthwhile freedoms to the Neuroprotection market during the estimate time frame. The Middle East and Africa Neuroprotection market is required to develop affected by expanding geological presence of significant makers in the area through essential consolidations and acquisitions, expansion in government drives to advance innovative work drug area in the district is relied upon to drive the Neuroprotection market in the locale during the figure time frame.

The global Neuroprotection market is segmented as given below:

Global Neuroprotection Market Revenue, by Product Type, 2015–2025

  • Free Radical Trapping Agents (Antioxidants)
  • Glutamate Antagonists (Anti-Excitotoxic Agents)
  • Apoptosis Inhibitors
  • Anti-inflammatory Agents
  • Neurotrophic Factors (NTFs)
  • Metal Ion Chelators
  • Stimulants
  • Others

Global Neuroprotection Market Revenue, By Application, 2015-2025

  • Prevention
  • Treatment

Global Neuroprotection Market Revenue, By Geography, 2015–2025

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Spain
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC countries
  • South Africa
  • Israel
  • Rest of Middle East & Africa

TABLE OF CONTENT

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology

3. Executive Summary
3.1. Global Neuroprotection Market Size (US$ Mn) and Distribution, by Region, 2017 and 2025
3.2. Global Neuroprotection Market: Market Snapshot

4. Market Overview
4.1. Global Neuroprotection Market: Product Overview
4.2. Global Neuroprotection Market: Key Industry Developments

5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Global Neuroprotection Market Outlook
5.6. Porters Five Forces
5.7. Pipeline Analysis
5.8. Mergers & Acquisition
5.9. Product mapping

6. Global Neuroprotection Market Analysis, by Product
6.1. Introduction
6.2. Key Insights
6.3. Global Neuroprotection Market Value Share Analysis, by Product
6.4. Global Neuroprotection Market Value (US$ Mn) Forecast , by Product
6.4.1. Free Radical Trapping Agents (Antioxidants)
6.4.2. Glutamate Antagonists (Anti-Excitotoxic Agents)
6.4.3. Apoptosis Inhibitors
6.4.4. Anti-inflammatory Agents
6.4.5. Neurotrophic Factors (NTFs)
6.4.6. Metal Ion Chelators
6.4.7. Stimulants
6.4.8. Others
6.5. Global Neuroprotection Market Attractiveness, by Product

7. Global Neuroprotection Market, By Application
7.1.  Global Neuroprotection Market Value Share Analysis, by Application
7.2. Global Neuroprotection Market Value (US$ Mn) Forecast, by Application
7.2.1. Prevention
7.2.2. Treatment
7.3. Global Neuroprotection Market Attractiveness Analysis, by Application
7.3.1. Prevention
7.3.2. Treatment

8. Global Neuroprotection Market Analysis, by Region
8.1. Global Neuroprotection Market Forecast, by Region, 2015–2025
8.1.1. North America
8.1.2. Europe
8.1.3. Asia Pacific
8.1.4. Latin America
8.1.5. Middle East & Africa
8.2. Global Neuroprotection Market Value Share Analysis, by Region
8.3. Global Neuroprotection Market Attractiveness Analysis, by Region

9. North America Neuroprotection Market Analysis
9.1. North America Neuroprotection Market Key Findings
9.2. North America Neuroprotection Market Overview
9.3. North America Neuroprotection Market Value Share Analysis, by Product
9.3.1. Free Radical Trapping Agents (Antioxidants)
9.3.2. Glutamate Antagonists (Anti-Excitotoxic Agents)
9.3.3. Apoptosis Inhibitors
9.3.4. Anti-inflammatory Agents
9.3.5. Neurotrophic Factors (NTFs)
9.3.6. Metal Ion Chelators
9.3.7. Stimulants
9.3.8. Others
9.4. North America Neuroprotection Market Value Share Analysis, by Application
9.4.1. Prevention
9.4.2. Treatment
9.5. North America Neuroprotection Market Forecast, by Country
9.5.1. U.S.
9.5.2. Canada
9.6. North America Neuroprotection Market Attractiveness Analysis
9.6.1. By Product
9.6.2. By Application
9.6.3. By Country
9.7. Trends

10. Europe Neuroprotection Market Analysis

…….

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/112020/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi